Intrexon Profile

14.19
USD 0.22  1.57%
26%
74%

Intrexon exotic insider transaction detected

Intrexon Corporation insider trading alert for general transaction of common stock by Randal Kirk, Chief Executive Officer, on September 17, 2018. This event was filed by Intrexon Corp with SEC on 2016-02-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Intrexon Summary

Intrexon Corporation (XON) is traded on New York Stock Exchange in USA. It is located in 20374 Seneca Meadows Parkway and employs 906 people. The company currently falls under 'Mid-Cap' category with total capitalization of 1.99 B. Intrexon Corporation runs under Healthcare sector within Biotechnology industry. This company has 136.99 M outstanding shares of which 31.64 M shares are at this time shorted by investors with about 26.07 days to cover shorted positions. Intrexon Corporat has about 81.13 M in cash with (62.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.59.
Check Intrexon Probability Of Bankruptcy

Ownership Allocation (%)

Intrexon Target Price Odds Analysis

Odds Below 14.19HorizonTargetOdds Above 14.19
17.23%30 days 14.19 82.58%
Based on normal probability distribution, the odds of Intrexon to move above current price in 30 days from now is about 82.58% (This Intrexon Corporation probability density function shows the probability of Intrexon Stock to fall within a particular range of prices over 30 days) .

Intrexon Top Holders

Intrexon Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Intrexon Key Fundamentals

Intrexon Against Markets

Intrexon Current Ratings

Intrexon Corporation 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
48 
Equity ratings for Intrexon Corporation are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Intrexon Corporation operates in the synthetic biology field in the United States. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland. Intrexon operates under Biotechnology classification in USA and traded on New York Stock Exchange. It employs 906 people. more
NameIntrexon Corporation
Chairman of the Board, CEORandal KirkView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address20374 Seneca Meadows Parkway
ExchangeNew York Stock Exchange
CIK Number0001356090
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.dna.com
Phone301 556 9900
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

Intrexon Directors

Intrexon Corporate Directors

Steven Frank Independent Director
Cesar Alvarez Independent Director
Dean Mitchell Independent Director
See also Your Current Watchlist. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Search macroaxis.com